Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis

NCT00004690 is registered in ClinicalTrials.gov with Cellegy Pharmaceuticals as lead sponsor.

NCT NCT00004690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
Lead sponsor
Cellegy Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1996
Completion date
September 30, 1998
Enrollment
90
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ichthyosis